Everything You Need To Know About A Successful IND-Enabling Program

Drug development flows from knowledge gained through basic research. As we deepen our understanding of how disease affects critical pathways and how we might manipulate normal functions for patient benefit, we identify and establish targets for therapeutic action. Any new therapy requires precise and comprehensive characterization of a its efficacy and safety properties.

To lower costs and make the most of your resources, you need a thoughtful, strategic plan. Considering all aspects of your program before you begin allows you to conserve financial resources without compromising the quality of data and the success of your program.

Evolving market pressures are changing the focus of the drug development industry, further accelerating early phases to create late-stage pipeline growth. This interactive E-Book will help you understand how and when to plan your preclinical IND-enabling program as an integral part of meeting specific milestones necessary to timely and efficient IND submission.